Neuronetics Sees Q1 Sales $33.000M-$35.000M vs $37.233M Est

Benzinga Newsdesk www.benzinga.com Positive 80.8%

Neg 0% Neu 0% Pos 80.8%

Neuronetics (NASDAQ:STIM) sees Q1 sales of $33.000 million-$35.000 million vs $37.233 million analyst estimate.

Comments

No comments yet. Be the first!